J. Gai

Blocking the PD-1-PD-L1 axis by a novel PD-1 specific nanobody expressed in yeast as a potential therapeutic for immunotherapy.

Yakun Wan, Linlin Ma, D. Ju, 2019, Biochemical and biophysical research communications.

A potent neutralizing nanobody against SARS‐CoV‐2 with inhaled delivery potential

Yakun Wan, Yanmin Zhang, Yadong Chen, 2020, bioRxiv.

A novel bispecific nanobody with PD-L1/TIGIT dual immune checkpoint blockade.

Yakun Wan, Linlin Ma, Guanghui Li, 2020, Biochemical and biophysical research communications.

Preclinical development of a novel CD47 nanobody with less toxicity and enhanced anti-cancer therapeutic potential

Yakun Wan, Siyuan Zhang, Linlin Ma, 2020, Journal of Nanobiotechnology.

Preclinical development of a long-acting trivalent bispecific nanobody targeting IL-5 for the treatment of eosinophilic asthma

Yakun Wan, Linlin Ma, Guanghui Li, 2022, Respiratory Research.

TROP2-directed nanobody-drug conjugate elicited potent antitumor effect in pancreatic cancer

Guanghui Li, Xuyao Zhang, Cailing Xu, 2023, Journal of Nanobiotechnology.

A humanized trivalent Nectin-4-targeting nanobody drug conjugate displays potent antitumor activity in gastric cancer

Guanghui Li, Yanfei Li, M. Zhu, 2024, Journal of nanobiotechnology.